Quarter Financials
Lineage Cell Therapeutics, Inc. (LCTX)
$1.57
+0.02 (+1.29%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
|---|
| Net Income | -7 | -7 | -29 | -8 | -5 | -1 | 2 | -8 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -351 | -344 | -337 | -308 | -300 | -295 | -294 | -296 |
|---|
|
Year
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
|---|
| Capital Expenditure | - | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
|---|
| Net PPE | 4 | 5 | 5 | 5 | 5 | 5 | 6 | 5 |
|---|
|
Year
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
2020 Q3
|
|---|
| New Purchases | - | - | - | - | - | - | - | - |
|---|
| Intangible and Goodwill | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
|---|